No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditions
|
- |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D01
- Name in latin
- Carcinoma in situ hepatis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of rectum
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of rectum
- Carcinoma in situ of other and unspecified digestive organs
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 174 | 86 | 84 |
| Only index persons | 103 | 52 | 51 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 71.50 | 70.93 | 71.69 |
| Only index persons | 70.19 | 69.41 | 70.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 262 | 108 | 154 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.07 |
| Median age at first event (years) | 70.09 | 69.02 | 70.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 233
- Matched controls
- 2328
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
89.8
136.0
148
44
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
62.7
131.7
157
74
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
+∞
105.4
93
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
70.5
64
*
C209, 8211, 2
ICD-O-3
NA
+∞
61.2
56
*
WX402
NOMESCO Finland
General anaesthesia
12.4
53.4
110
157
C209, 8148, 2
ICD-O-3
NA
+∞
53.2
49
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
49.8
46
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
39.7
49.4
62
21
UJF32
NOMESCO Finland
Coloscopy
8.1
46.4
141
370
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
43.1
40
*
130
Kela drug reimbursment
Malignant tumour
+∞
42.0
39
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
247.4
41.3
41
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
21.7
38.9
58
35
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
14.7
32.9
57
50
B01AB05
ATC
enoxaparin; parenteral
5.3
29.7
121
394
L01BC06
ATC
capecitabine; oral
+∞
28.7
27
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
27.7
26
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
27.7
26
*
JFF23
NOMESCO Finland
Transversostomy
151.9
26.2
27
*
JGA73
NOMESCO Finland
Transanal excision of lesion of rectum
145.6
25.1
26
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
23.3
22
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.0
23.2
56
89
UJG02
NOMESCO Finland
Proctoscopy
27.3
22.9
31
13
JN4AD
NOMESCO Finland
Body CT examination
14.9
22.1
37
29
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
20.1
19
*
WF002
NOMESCO Finland
Radical radiotherapy
114.9
19.9
21
*
WX600
NOMESCO Finland
Single shot through catheter
114.9
19.9
21
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
76.4
19.0
21
*
JN4BD
NOMESCO Finland
Extensive body CT
9.1
17.7
38
49
H02AB02
ATC
dexamethasone; systemic
24.1
17.3
24
11
B01AB10
ATC
tinzaparin; parenteral
9.8
16.7
34
40
R4110
NOMESCO Finland
Physiotherapy
3.7
16.6
92
350
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.1
15.9
23
12
JG1CG
NOMESCO Finland
Extensive MRI of rectum
+∞
15.8
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
15.8
15
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
7.2
15.4
38
61
A04AA01
ATC
ondansetron; systemic, rectal
20.1
15.0
22
12
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
14.7
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.7
14
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
14.7
14
*
JGA75
NOMESCO Finland
Endoscopic microsurgical excision of lesion of rectum
+∞
14.7
14
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
14.7
76
270
JG1BG
NOMESCO Finland
MRI of rectum
159.6
14.6
15
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
17.2
14.2
22
14
JGA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in rectum
57.0
14.0
16
*
8140/2-C20.9
ICD-O-3
Adenocarcinoma in situ, NOS, of rectum, NOS
+∞
13.7
13
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
13.7
13
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
13.5
50
131
K62.1
ICD-10 Finland
Rectal polyp
18.7
12.7
19
11
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
12.6
84
356
D01.2
ICD-10 Finland
Carcinoma in situ: Rectum
+∞
12.6
12
*
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
+∞
12.6
12
*
C209, 8213, 2
ICD-O-3
NA
+∞
12.6
12
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
137.1
12.6
13
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.0
12.4
28
39
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
13.5
11.9
20
16
WZC30
NOMESCO Finland
Teaching
4.4
11.7
44
116
A04AA02
ATC
granisetron; systemic, transdermal
68.5
11.7
13
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
11.6
11
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
11.6
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.6
11
*
TJF80
NOMESCO Finland
Ostomy education
63.0
10.7
12
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
115.0
10.5
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.5
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
34.2
10.4
13
*
Z71.8
ICD-10 Finland
Other specified counselling
2.9
9.7
69
297
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
9.6
72
321
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
6.0
9.5
26
48
D75
ICPC
Malignant neoplasm colon/rectum
+∞
9.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
9.4
9
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
+∞
9.4
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
8.9
97
529
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
93.3
8.5
9
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.4
8.5
30
75
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.4
8
*
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
7.0
8.1
19
29
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
7.9
7.8
17
23
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
26.0
7.6
10
*
UJF30
NOMESCO Finland
Ileoscopy through colon
3.5
7.6
35
111
N02BE01
ATC
paracetamol; systemic, rectal
2.9
7.5
206
1694
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.7
7.4
24
55
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
+∞
7.3
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
7.0
39
142
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.0
6.9
18
32
L02AE02
ATC
leuprorelin; implant, parenteral
23.3
6.7
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.7
6.6
11
9
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
71.7
6.5
7
*
JN4CD
NOMESCO Finland
Very extensive body CT
8.5
6.4
13
16
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.5
6.3
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
157
118
31.70
184.21
6.1
1.3
ug/l
12.9
5.2
0.54
130
91
(3022145) Colonoscopy Study observation
185
204
28.45
175.22
2.3
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
216
875
9.36
53.72
5.5
3.5
—
—
—
0
0
(4035726)
57
59
12.07
51.12
1.6
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
79
144
7.42
44.55
1.3
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
164
585
5.82
44.40
3.6
2.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
98
227
6.30
43.32
1.8
2.3
umol/l
5.6
7.7
1.04
87
195
(3032080) INR in Blood by Coagulation assay
204
895
6.78
42.71
12.0
10.1
inr
1.3
1.4
1.09
59
239
(3024561) Albumin [Mass/volume] in Serum or Plasma
203
906
6.51
41.05
7.7
3.4
g/l
34.5
35.7
2.22
198
842
(40768804) Tissue Pathology biopsy report
162
632
5.10
37.65
2.7
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
81
182
5.99
36.41
1.9
2.0
u/l
34.4
31.6
0.36
69
153
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
128
448
4.63
33.37
3.7
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
204
1031
5.42
32.16
10.5
3.8
umol/l
11.1
12.2
1.15
199
968
(3002582) Erythrocytes [#/volume] in Urine
139
624
3.61
23.50
3.8
2.9
e6/l
21.1
162.5
0.75
101
478
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
99
5.71
23.05
10.2
8.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
118
482
3.63
23.02
1.5
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
209
1250
4.32
22.09
7.3
4.1
mmol/l
6.7
6.8
0.34
200
1167
(36304419) Bacteria [Presence] in Urine
122
539
3.36
20.53
3.5
2.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
82
282
3.78
20.44
3.1
2.3
%
21.5
23.5
0.53
74
244
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
327
3.61
20.03
3.2
2.8
e6/l
0.9
1.3
0.70
44
166
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
148
753
3.22
19.32
3.6
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
124
572
3.22
19.12
3.7
2.8
e6/l
0.2
0.5
1.34
86
420
(3018095) Leukocytes [#/volume] in Urine
144
729
3.17
18.82
4.6
3.4
e6/l
42.7
133.2
1.38
103
513
(3023368) Bacteria identified in Blood by Culture
121
555
3.19
18.76
6.6
3.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
63
6.05
18.13
3.0
2.3
u/ml
0.3
0.4
0.21
15
32
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
175
1008
3.22
17.94
9.7
5.4
mmol/l
1.2
1.2
2.36
148
871
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
540
3.06
17.22
2.3
2.1
mg/l
2.7
2.9
0.76
101
461
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
163
923
3.03
16.82
8.1
5.0
mmol/l
1.2
1.2
1.92
152
818
(42870588) Differential panel, method unspecified - Blood
126
650
2.81
15.00
7.1
5.2
—
—
—
0
0
(3026782) Osmolality of Urine
91
396
2.99
14.88
3.5
2.5
mosm/kgh2o
525.0
569.3
1.29
81
325
(3018418) pH of Serum or Plasma
114
567
2.79
14.45
4.5
3.4
ph
7.4
7.4
0.01
26
88
(3021589) Normoblasts [#/volume] in Blood
153
884
2.76
14.42
16.1
7.7
e9/l
0.0
0.0
0.48
121
727
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
361
2.95
13.93
2.9
2.6
e6/l
0.6
1.1
1.59
39
202
(40768800) Prostate Pathology biopsy report
15
14
11.30
13.87
1.2
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
159
955
2.69
13.58
6.7
5.2
%
23.8
27.0
3.02
153
878
(3006504) Eosinophils/100 leukocytes in Blood
155
935
2.61
12.88
6.8
5.0
%
2.7
3.1
1.06
150
857
(3013650) Neutrophils [#/volume] in Blood by Automated count
175
1123
2.68
12.73
13.3
5.8
e9/l
4.2
4.3
0.17
145
982
(3019069) Monocytes/100 leukocytes in Blood
155
942
2.58
12.57
6.9
5.2
%
9.0
8.7
0.59
150
867
(3031040) Bacteria [#/volume] in Urine by Automated count
195
1345
2.76
11.84
5.1
4.2
e6/l
5107.8
711.3
—
6
23
(3003396) Base excess in Arterial blood by calculation
62
246
2.99
11.67
9.3
6.1
mmol/l
0.5
1.5
1.17
52
198
(3019198) Lymphocytes [#/volume] in Blood
161
1026
2.48
11.36
6.5
4.9
e9/l
1.7
1.8
0.25
140
898
(3015377) Calcium [Moles/volume] in Serum or Plasma
119
668
2.43
11.07
5.1
2.0
mmol/l
2.3
2.3
0.08
108
541
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
39
120
3.64
11.05
1.4
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
161
1040
2.42
10.81
6.9
4.9
e9/l
0.2
0.2
1.36
139
914
(3001604) Monocytes [#/volume] in Blood
157
1004
2.41
10.78
6.5
4.8
e9/l
0.6
0.6
0.29
132
861
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
34
97
3.88
10.73
12.8
7.2
mmol/l
24.4
25.0
0.40
34
88
(3006315) Basophils [#/volume] in Blood
157
1011
2.38
10.51
6.5
4.8
e9/l
0.0
0.0
1.98
132
875
(3026008) Bacteria identified in Urine by Culture
111
623
2.36
10.12
3.3
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
47
172
3.11
10.10
12.3
6.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
214
1607
2.81
9.93
4.5
4.1
mm/h
16.0
12.6
1.89
208
1455
(3027945) Reticulocytes/100 erythrocytes in Blood
61
262
2.73
9.80
3.0
2.2
%
1.9
1.7
0.94
56
234
(3000850) Epithelial cells [#/volume] in Urine
84
424
2.44
9.66
3.0
2.2
e6/l
4.3
4.9
0.23
75
367
(3023520) Reticulocytes [#/volume] in Blood
50
200
2.85
9.15
4.4
2.3
e9/l
68.8
67.8
0.07
30
160
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
252
2118
5.97
9.00
28.2
12.7
mg/l
33.2
23.9
3.97
241
1641
(3019550) Sodium [Moles/volume] in Serum or Plasma
255
2252
5.95
8.69
34.5
15.7
mmol/l
139.5
139.8
0.87
255
2180
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
111
659
2.19
8.52
2.8
2.2
u/l
60.9
57.0
0.45
104
613
(3023103) Potassium [Moles/volume] in Serum or Plasma
255
2257
5.86
8.51
35.2
15.8
mmol/l
4.0
4.0
1.63
255
2185
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
68
329
2.44
8.45
1.7
1.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
255
2260
5.80
8.33
35.2
15.3
umol/l
89.4
81.8
1.45
255
2260
(3003458) Phosphate [Moles/volume] in Serum or Plasma
58
263
2.55
8.26
7.0
4.8
mmol/l
1.0
1.0
0.39
53
238
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
47
4.52
8.09
1.8
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
213
2.67
8.07
4.7
2.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
255
2267
5.67
7.95
16.8
9.0
u/l
24.2
25.5
0.83
255
2169
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
24
6.11
7.94
1.5
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
146
992
2.07
7.60
4.0
3.6
estimate
0.0
0.0
0.00
38
157
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
241
2019
3.42
7.47
31.3
11.6
ml/min/173m2
73.8
76.0
0.85
205
1621
(3044889) 12 lead EKG panel
201
1555
2.26
7.24
4.9
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
190
1442
2.16
7.12
5.4
4.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
50
226
2.50
7.12
1.7
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
27
5.42
7.05
4.2
2.1
pg
35.3
33.9
0.82
14
27
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
50
227
2.49
7.05
1.7
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
144
994
2.00
6.96
5.5
5.0
estimate
0.0
0.0
0.00
43
154
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
126
832
1.99
6.90
2.4
2.2
nmol/l
79.9
77.2
0.45
114
726
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
33
126
2.85
6.52
1.3
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
144
1011
1.94
6.45
4.0
3.7
estimate
0.0
0.0
0.00
39
151
(3042936) Bacteria identified in Isolate by Culture
61
314
2.23
6.44
2.6
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
45
206
2.43
6.20
1.4
1.9
ug/g
217.7
148.4
0.29
37
163
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
174
1317
1.96
6.07
4.0
3.0
u/l
60.7
50.1
0.75
161
1226
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
115
761
1.91
6.04
4.2
3.1
ng/l
1942.9
1414.7
0.73
105
651
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
27
5.01
6.04
3.2
1.6
e9/l
3.8
4.8
0.65
13
27
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
28
4.83
5.80
4.2
2.3
%
51.7
57.5
0.45
13
28
(3041096) Erythrocytes [Presence] in Urine by Automated
87
531
1.96
5.77
4.4
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
35
147
2.59
5.76
5.6
3.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
411
2.00
5.44
4.9
2.1
mmol/l
2.5
2.4
1.00
66
349
(3007461) Platelets [#/volume] in Blood
255
2340
4.36
5.41
42.7
18.8
e9/l
239.3
240.3
0.09
250
2268
(3024731) MCV [Entitic volume]
255
2341
4.34
5.41
42.7
18.8
fl
91.8
91.4
0.77
255
2291
(3015736) pH of Urine
116
793
1.83
5.34
3.0
3.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
255
2344
4.29
5.24
43.2
18.9
g/l
127.4
136.9
16.18
255
2293
(3035941) MCH [Entitic mass]
255
2342
4.32
5.23
42.5
18.7
pg
30.3
30.4
0.70
255
2292
(40758558) Short blood count panel - Blood
76
457
1.93
5.20
8.7
4.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
56
304
2.07
5.09
1.4
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
19
61
3.28
5.02
2.3
1.2
mg/l
66.3
49.1
0.42
13
51
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
19
61
3.28
5.02
2.3
1.2
mg/l
59.6
35.5
0.71
13
51
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
135
983
1.77
4.91
2.3
2.0
pmol/l
92.2
95.1
0.36
90
514
(40761511) CBC panel - Blood by Automated count
247
2200
3.14
4.87
25.9
12.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
38
3.84
4.71
3.3
1.6
%
17.1
16.1
—
9
18
(3004588) Protein electrophoresis panel - Serum or Plasma
31
139
2.40
4.46
1.7
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
10
22
4.69
4.34
1.6
1.1
e6/l
698.8
2710.1
—
5
15
(3025159) Blasts/100 leukocytes in Blood
29
128
2.42
4.31
4.7
4.1
%
0.1
0.0
—
8
29
(3021440) Promyelocytes/100 leukocytes in Blood
30
135
2.38
4.28
4.5
4.0
%
0.0
0.0
—
9
32
(40760888) Immunoglobulin light chains.free panel - Serum
14
41
3.55
4.25
1.6
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
191
1581
1.77
4.05
4.4
3.6
pmol/l
15.4
15.0
1.13
173
1415
(3026493) Urate [Moles/volume] in Serum or Plasma
88
593
1.73
4.02
3.3
2.4
umol/l
3488.3
9856.6
0.89
77
513
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
78
508
1.76
4.02
1.8
1.7
pmol/l
460.0
437.8
0.23
66
419
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
17
59
3.01
3.98
2.4
1.2
—
0.8
—
0
5
(3021960) Folate [Moles/volume] in Serum or Plasma
84
562
1.73
3.93
1.8
1.6
nmol/l
19.4
20.4
0.28
78
477
(3017181) Myelocytes/100 leukocytes in Blood
30
141
2.27
3.89
4.5
4.0
%
0.3
0.9
—
9
36
(3045788) Cell count panel - Pleural fluid
9
15
6.17
3.85
1.7
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
73
472
1.76
3.84
3.8
3.8
ng/l
276.3
347.8
0.13
63
395
(3049717) Cytology report of Urine Cyto stain
19
72
2.77
3.82
3.9
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
8
8.95
3.79
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
215
1862
1.86
3.68
35.3
13.8
%
37.8
39.9
3.84
157
1226
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
64
403
1.78
3.67
1.2
1.3
u/ml
2.5
1.6
0.30
19
120
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
46
3.16
3.58
1.3
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
9
7.95
3.58
3.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
27
126
2.27
3.56
4.1
4.1
%
0.3
0.3
—
6
27
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
81
550
1.68
3.54
3.7
2.6
ug/l
0.7
0.8
0.26
57
377
(40760892) CBC W Ordered Manual Differential panel - Blood
64
407
1.76
3.54
4.7
4.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
36
3.45
3.52
5.4
2.1
—
—
—
0
0
(4034850)
0
86
0.00
3.38
0.0
9.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
14
5.86
3.36
1.5
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
116
2.28
3.35
2.1
2.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
222
1965
1.85
3.23
5.4
4.5
mu/l
2.0
2.6
0.49
204
1761
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
28
3.67
3.23
1.4
1.3
pmol/l
109.5
58.1
—
10
28
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
139
1099
1.56
3.17
2.3
2.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
14
50
2.90
3.14
2.9
2.3
kpa
8.1
7.9
0.28
14
42
(36660697) Celiac disease serology panel - Serum
28
141
2.10
3.09
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
77
2.44
2.89
3.6
3.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
97
2.27
2.86
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
97
2.27
2.86
1.2
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
91
2.30
2.81
1.5
1.2
g/l
7.1
7.6
0.89
15
69
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
91
2.30
2.81
1.5
1.2
g/l
3.9
3.9
0.09
13
65
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
91
2.30
2.81
1.5
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
42
252
1.79
2.81
1.5
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
29
154
1.99
2.79
4.7
4.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
31
170
1.93
2.73
1.3
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
10
6.11
2.71
1.5
1.4
ug/l
14.7
18.3
—
6
10
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
25
3.69
2.60
4.2
1.8
u/ml
3.3
150.7
—
9
25
(3000093) Morphology [Interpretation] in Blood Narrative
8
20
4.09
2.59
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
234
2140
1.87
2.58
4.9
5.0
mmol/l
5.9
6.0
0.90
220
1938
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
102
786
1.49
2.45
4.5
3.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
125
1004
1.47
2.43
5.5
4.0
ug/l
2.0
2.1
0.08
115
895
(3045424) Erythrocytes [Presence] in Urine
9
27
3.41
2.41
2.7
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
40
2.83
2.40
3.2
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
31
179
1.83
2.35
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
74
538
1.52
2.33
4.9
3.9
estimate
0.0
0.0
0.00
41
153
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
304
0.46
2.28
6.9
6.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
18
3.96
2.26
1.7
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
18
3.96
2.26
2.0
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
18
3.96
2.26
1.6
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
102
796
1.46
2.26
4.4
3.8
%
20.5
24.0
1.88
54
384
(3019309) Folate [Moles/volume] in Red Blood Cells
65
463
1.54
2.24
2.1
1.7
nmol/l
1079.9
1178.8
0.36
49
352
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
48
2.57
2.22
1.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
74
2.24
2.19
3.9
2.3
g/l
0.7
0.3
—
8
21
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
225
2057
1.66
2.19
6.8
6.5
mmol/mol
40.0
40.4
0.32
213
1899
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
43
2.63
2.12
1.5
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
56
2.39
2.08
1.7
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
44
2.57
2.04
1.8
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
8
26
3.14
2.03
3.1
1.4
mmol/l
1.5
1.7
—
8
26
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
32
2.88
2.02
3.9
2.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
78
2.12
1.95
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
33
2.79
1.95
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
22
3.24
1.89
1.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
20
108
1.92
1.87
6.0
3.8
mmol/l
23.2
24.4
0.68
20
96
(3007164) IgA [Mass/volume] in Serum or Plasma
52
367
1.52
1.86
1.4
1.2
g/l
2.8
2.9
0.04
29
216
(3009445) Proteinase 3 Ab [Units/volume] in Serum
17
87
2.02
1.84
1.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
35
2.63
1.82
1.9
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
23
3.10
1.81
3.0
1.3
%
87.6
90.4
—
7
23
(3007853) Bacteria identified in Skin by Aerobe culture
38
252
1.59
1.78
2.4
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
36
2.55
1.75
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
36
2.55
1.75
1.2
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
2.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
13
3.90
1.72
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
214
1.62
1.70
1.4
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
25
2.85
1.66
2.0
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
25
2.85
1.66
3.3
5.3
mmol/l
9.2
7.4
—
7
19
(1761868) Lipid panel - Serum or Plasma
89
711
1.38
1.65
3.6
3.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
33
217
1.60
1.61
6.5
3.4
mmol/l
0.6
1.9
0.72
27
176
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
234
2199
1.60
1.56
5.2
5.5
mmol/l
2.5
2.7
1.47
214
2009
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
461
1.42
1.55
4.5
1.7
mg/l
2.5
1.1
1.97
51
371
(3011397) Hemoglobin [Presence] in Urine by Test strip
62
472
1.41
1.51
2.7
3.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
38
2.42
1.47
1.1
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
28
2.54
1.46
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
28
2.54
1.46
1.4
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
39
2.35
1.44
1.9
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
39
2.35
1.44
1.4
1.5
—
—
—
0
0
(4281824)
5
16
3.16
1.44
1.6
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
22
2.77
1.44
2.2
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
9
40
2.29
1.41
1.4
1.2
u/l
203.5
19.4
—
9
34
(3003338) MCHC [Mass/volume]
193
1762
1.36
1.39
38.0
16.9
g/l
329.5
332.6
4.39
193
1751
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
20
317
0.60
1.39
4.1
5.1
%
31.3
31.7
0.06
13
209
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
41
2.24
1.38
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
23
2.65
1.37
2.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
68
1.96
1.36
2.3
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
111
940
1.31
1.36
3.6
3.7
ng/l
35.8
78.2
0.61
87
685
(3012544) pH of Venous blood
33
229
1.50
1.30
6.6
3.5
—
—
—
0
0
(4306422)
6
25
2.43
1.25
1.7
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
25
2.43
1.25
1.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
25
2.43
1.25
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.34
1.19
1.5
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
26
2.34
1.19
1.5
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
11
58
1.94
1.14
5.4
2.6
mmol/l
24.8
24.7
0.02
11
47
(3023183) Ammonium ion [Moles/volume] in Plasma
10
51
2.00
1.12
7.8
2.2
umol/l
33.7
33.5
—
10
45
(3042631) Mycobacterium sp identified in Specimen
5
21
2.41
1.09
1.8
2.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
190
0.56
1.07
1.9
3.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
33
2.15
1.06
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
33
2.15
1.06
1.4
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
34
2.09
1.03
1.0
1.7
—
—
—
0
0
(3013512) EKG study
83
698
1.28
1.03
4.6
4.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
54
1.89
0.98
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
231
0.63
0.95
1.5
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
27
2.25
0.94
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
28
2.17
0.92
2.2
2.3
—
—
—
0
0
(3009343) pH of Capillary blood
21
144
1.50
0.90
3.8
3.8
ph
7.4
7.4
—
6
11
(3000330) Specific gravity of Urine by Test strip
17
111
1.57
0.90
4.2
3.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
225
2149
1.33
0.85
4.7
4.9
mmol/l
4.4
4.5
0.76
209
1969
(3037756) Immunofixation for Serum or Plasma
6
32
1.90
0.82
2.0
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
47
1.72
0.81
1.5
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
21
148
1.46
0.81
4.0
3.7
kpa
5.1
5.0
0.05
21
138
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
96
0.51
0.80
1.6
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
27
0.00
0.78
0.0
3.3
—
29.8
—
0
9
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
83
722
1.22
0.75
2.1
2.1
u/l
101.8
315.0
1.34
78
672
(21494434) Karyotype in Bone marrow
5
24
2.10
0.75
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.6
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
26
1.94
0.71
1.6
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
69
1.62
0.69
1.5
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
91
805
1.20
0.69
4.2
3.9
mg/mmol
29.3
6.8
1.34
59
501
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
222
2133
1.27
0.67
4.6
4.9
mmol/l
1.4
1.4
0.23
205
1949
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
215
2060
1.24
0.65
4.1
4.4
mmol/l
1.3
1.3
0.12
199
1871
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
129
1.42
0.65
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
87
1.52
0.64
1.5
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
29
1.74
0.64
1.2
1.2
pmol/l
195.4
302.7
—
5
24
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
79
1.54
0.63
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
69
600
1.20
0.62
1.6
1.7
mmol/l
1.3
1.4
0.15
59
497
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
30
1.68
0.61
1.0
1.1
u/ml
364.4
255.3
—
5
16
(3028026) IgM [Mass/volume] in Serum or Plasma
16
114
1.43
0.60
3.2
1.3
g/l
2.1
1.2
0.55
16
105
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
196
1.30
0.55
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
66
1.54
0.53
5.5
4.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
332
1.21
0.45
1.3
1.3
u/ml
27.3
12.0
0.35
15
112
(3019225) pH of Specimen
17
217
0.77
0.43
3.2
3.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
31
1.62
0.43
1.0
1.4
—
181.9
—
0
11
(3052851) Hemolysis interference index of Serum or Plasma
8
57
1.42
0.42
1.4
3.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
57
1.42
0.42
6.1
3.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
15
0.00
0.41
0.0
1.2
—
7.6
—
0
15
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
59.2
—
0
10
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
60
1.34
0.40
1.6
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
36
1.40
0.38
5.0
3.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
22
180
1.24
0.37
6.0
2.8
kpa
5.1
4.4
0.60
22
169
(3036481) Cortisol [Moles/volume] in Serum or Plasma
23
190
1.23
0.36
2.6
1.6
nmol/l
420.8
359.8
1.22
23
174
(3000492) Spirometry study
22
182
1.23
0.34
1.7
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
53
1.33
0.31
1.3
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
249
0.83
0.30
1.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
81
758
1.10
0.26
3.1
3.1
mg/l
913.0
232.8
0.45
50
471
(4010399)
20
170
1.19
0.25
1.1
1.4
—
—
—
0
0
(1002224) Polysomnography panel
6
83
0.72
0.24
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
83
781
1.09
0.24
3.1
3.0
mmol/l
7.3
7.7
0.42
68
646
(3044290) Cell count panel - Cerebral spinal fluid
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
42
1.19
0.21
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
11
0.00
0.21
0.0
2.5
—
17.6
—
0
11
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4015189)
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
13.4
—
950.4
—
0
10
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
16.0
—
1623.2
—
0
10
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
105
0.75
0.21
1.4
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
12
0.00
0.21
0.0
2.6
—
52.3
—
0
6
(3023511) Choriogonadotropin [Units/volume] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.6
—
153.1
—
0
12
(3022621) pH of Urine by Test strip
17
145
1.18
0.21
2.4
2.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
60
1.17
0.18
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
110
1.19
0.17
3.9
3.9
—
—
—
0
0
(3020891) Body temperature
11
94
1.18
0.13
5.0
4.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
356
1.08
0.12
1.4
1.3
iu/ml
16.8
35.2
1.92
14
114
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
45
1.11
0.10
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
45
1.11
0.10
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
114
0.87
0.09
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
47
1.07
0.09
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
147
1.09
0.07
1.1
1.3
—
50.4
—
0
11
(3019832) Treponema pallidum Ab [Presence] in Serum
7
81
0.86
0.07
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
86
1.05
0.07
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
46
476
0.96
0.06
3.7
4.0
kg/l
1.0
1.0
—
6
70
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
141
1.07
0.03
1.7
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
113
1.06
0.02
1.4
1.2
iu/ml
90.2
117.1
—
7
38
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
117
0.94
0.02
5.8
2.5
%
1.1
1.2
0.14
11
117
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
133
1.06
0.01
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
17
166
1.03
0.00
2.1
2.5
—
17.4
—
0
6
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
89
1.01
0.00
1.3
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
79
0.88
0.00
1.4
2.2
u/l
40.3
41.7
—
7
67
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
5.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.1
—
2.6
—
0
9
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
170
1.00
0.00
4.6
2.0
ml/min/173m2
46.4
61.5
—
10
68
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4094501)
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
5.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1683.8
—
0
5
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
10.4
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
63.2
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
96
0.94
0.00
1.2
1.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
28.1
—
0
5
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_RECTUM_EXALLC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_INSITU_RECTUM_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_RECTUM_EXALLC – Carcinoma in situ of rectum
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data